Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter

Allergy and Asthma Proceedings

Volumn 34, Issue 1, 2013, Pages 42-51

  Given, John ^a   Taveras, Herminia ^b   Iverson, Harald ^b   Lepore, Mark ^b  

^a Allergy and Respiratory Center   (United States)

^b Teva Branded Pharmaceutical Products RandD Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUTEROL SULFATE HYDROFLUOROALKANE; BRONCHODILATING AGENT; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG;

ACCURACY; ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DEVICE SAFETY; DISEASE COURSE; DISEASE EXACERBATION; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; OPEN STUDY; OTALGIA; OTITIS MEDIA; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SINUS HEADACHE; SINUSITIS; THRUSH; TINEA VERSICOLOR; TOOTH PAIN; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ADOLESCENT; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; MALE; METERED DOSE INHALERS; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; YOUNG ADULT;

EID: 84874342044     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3647     Document Type: Article

References (16)

1. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma: Summary report 2007. J Allergy Clin Immunol 120(suppl 5):s94-s138, 2007.
2. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256-1276, 2001. (Pubitemid 32378468)
3. Hubner M, Hochhaus G, and Derendorf H. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. Immunol Allergy Clin North Am 25:469-488, 2005. (Pubitemid 41073457)
4. Teva Respiratory, LLC. PROAIR HFA (albuterol sulfate) inhalation aerosol prescribing information. Horsham, PA; July 2010.
5. Wasserman RL, Sheth K, Lincourt WR, et al. Real-world assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc 27:486-492, 2006. (Pubitemid 44916014)
6. Ogren RA, Baldwin JL, and Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy Asthma Immunol 75:485-489, 1995. (Pubitemid 26007533)
7. Rubin BK, and Durotoye L. How do patients determine that their metered-dose inhaler is empty? Chest 126:1134-1137, 2004. (Pubitemid 39391242)
8. GlaxoSmithKline. VENTOLIN HFA (albuterol sulfate) inhalation aerosol prescribing information. Research Triangle Park, NC; July 2009.
9. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry: Integration of dose-counting mechanisms into MDI drug products. March 2003. Available online at www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/ucm071731.pdf; accessed July 24, 2012.
10. Sheth K, Wasserman RL, Lincourt WR, et al. Fluticasone propionate/ salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. Int J Clin Pract 60:1218-1224, 2006. (Pubitemid 44363657)
11. Weinstein C, Staudinger H, Scott I, et al. Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med 105:979-988, 2011.
12. Shah S, White M, Uryniak T, and O'Brien CD. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. Allergy Asthma Proc 31:40-48, 2010.
13. LaForce C, Weinstein C, Nathan RA, et al. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. J Asthma 48:625-631, 2011.
14. Tennen H, Affleck G, Coyne JC, et al. Paper and plastic in daily diary research: Comment on Green, Rafaeli, Bolger, Shrout, and Reis. Psychol Methods 11:112-118, 2006. (Pubitemid 44084655)
15. Gong H Jr, Simmons MS, Clark VA, and Tashkin. Metered-dose inhaler usage in subjects with asthma: Comparison of Nebulizer Chronolog and daily diary recordings. J Allergy Clin Immunol 82:5-10, 1988.
16. Julius SM, Sherman JM, and Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 121:871-876, 2002. (Pubitemid 34251457)